HELEN L. COLLINS,HONG XIANG,JAMES HNATYSZYN,XIANG ZHANG
申请号：
BR112019023898
公开号：
BR112019023898A2
申请日:
2018.05.15
申请国别(地区):
BR
年份:
2020
代理人:
摘要：
this application concerns the use of antibodies against fibroblast growth factor receptor 2 (fgfr2), including antibodies against the fgfr2 isoform fgfr2-iiib (also known as fgfr2b), in the treatment of certain types of cancer in combination with mfolfox6 chemotherapy.este pedido refere-se ao uso de anticorpos contra o receptor 2 do fator de crescimento de fibroblastos (fgfr2), incluindo anticorpos contra a isoforma fgfr2 fgfr2-iiib (também conhecida como fgfr2b), no tratamento de certos tipos de câncer em combinação com a quimioterapia mfolfox6.
